Janus Henderson Group PLC Regeneron Pharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 98,134 shares of REGN stock, worth $68.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
98,134
Previous 100,424 2.28%
Holding current value
$68.9 Million
Previous $106 Million 2.26%
% of portfolio
0.06%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $2.35 Million - $2.75 Million
-2,290 Reduced 2.28%
98,134 $103 Million
Q2 2024

Aug 14, 2024
SELL
$883.2 - $1071.19 $3.15 Million - $3.82 Million
-3,568 Reduced 3.43%
100,424 $106 Million
Q1 2024

May 15, 2024
SELL
$902.69 - $993.35 $7.98 Million - $8.78 Million
-8,837 Reduced 7.83%
103,992 $100 Million
Q4 2023

Feb 14, 2024
SELL
$775.18 - $881.7 $7.43 Million - $8.45 Million
-9,584 Reduced 7.83%
112,829 $99.1 Million
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $24.3 Million - $29.7 Million
35,120 Added 40.23%
122,413 $101 Million
Q2 2023

Aug 14, 2023
SELL
$700.03 - $830.35 $76.8 Million - $91.2 Million
-109,778 Reduced 55.7%
87,293 $62.7 Million
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $34 Million - $41.3 Million
-49,951 Reduced 20.22%
197,071 $162 Million
Q4 2022

Feb 14, 2023
SELL
$705.89 - $766.39 $27 Million - $29.3 Million
-38,251 Reduced 13.41%
247,022 $178 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $74.5 Million - $94 Million
129,754 Added 83.43%
285,273 $197 Million
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $7.23 Million - $9.74 Million
-13,183 Reduced 7.81%
155,519 $91.9 Million
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $6.12 Million - $7.18 Million
-10,276 Reduced 5.74%
168,702 $118 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $10.1 Million - $12.5 Million
-18,668 Reduced 9.45%
178,978 $113 Million
Q3 2021

Nov 16, 2021
SELL
$574.03 - $680.96 $5.91 Million - $7.01 Million
-10,300 Reduced 4.95%
197,646 $120 Million
Q2 2021

Aug 16, 2021
SELL
$472.8 - $558.54 $12.5 Million - $14.7 Million
-26,381 Reduced 11.26%
207,946 $116 Million
Q1 2021

May 17, 2021
SELL
$446.73 - $548.2 $65.9 Million - $80.9 Million
-147,496 Reduced 38.63%
234,327 $111 Million
Q4 2020

Feb 16, 2021
BUY
$478.3 - $607.98 $19.2 Million - $24.5 Million
40,236 Added 11.78%
381,823 $184 Million
Q3 2020

Nov 16, 2020
BUY
$544.75 - $658.21 $25.4 Million - $30.7 Million
46,572 Added 15.79%
341,587 $191 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $127 Million - $166 Million
257,084 Added 677.77%
295,015 $184 Million
Q1 2020

May 14, 2020
BUY
$336.18 - $494.43 $3.15 Million - $4.63 Million
9,363 Added 32.77%
37,931 $18.5 Million
Q4 2019

Feb 18, 2020
SELL
$274.13 - $376.51 $55.7 Million - $76.5 Million
-203,166 Reduced 87.67%
28,568 $10.7 Million
Q3 2019

Nov 14, 2019
SELL
$273.46 - $318.39 $18.2 Million - $21.1 Million
-66,398 Reduced 22.27%
231,734 $64.3 Million
Q2 2019

Jul 31, 2019
SELL
$299.6 - $414.82 $39.6 Million - $54.8 Million
-132,020 Reduced 30.69%
298,132 $93.3 Million
Q1 2019

Apr 30, 2019
SELL
$372.08 - $439.57 $188 Million - $222 Million
-505,998 Reduced 54.05%
430,152 $177 Million
Q4 2018

Feb 06, 2019
SELL
$335.82 - $403.04 $203 Million - $244 Million
-605,891 Reduced 39.29%
936,150 $350 Million
Q3 2018

Nov 09, 2018
SELL
$351.14 - $408.51 $91.5 Million - $106 Million
-260,699 Reduced 14.46%
1,542,041 $623 Million
Q2 2018

Aug 10, 2018
BUY
$284.6 - $344.99 $57.9 Million - $70.1 Million
203,306 Added 12.71%
1,802,740 $622 Million
Q1 2018

May 14, 2018
SELL
$315.82 - $393.78 $23.5 Million - $29.3 Million
-74,406 Reduced 4.45%
1,599,434 $551 Million
Q4 2017

Feb 09, 2018
BUY
$358.63 - $469.95 $46.1 Million - $60.4 Million
128,510 Added 8.32%
1,673,840 $629 Million
Q3 2017

Nov 14, 2017
SELL
$431.38 - $504.0 $7.61 Million - $8.89 Million
-17,640 Reduced 1.13%
1,545,330 $0
Q2 2017

Aug 17, 2017
BUY
N/A
1,562,970
1,562,970 $768 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email